Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Hot Stocks
Galectin Therapeutics says DSMB recommends continuation of NAVIGATE study » 08:08
04/09/24
04/09
08:08
04/09/24
08:08
GALT

Galectin Therapeutics

$3.75 /

+0.03 (+0.81%)

Galectin Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Biotech Alert: Searches spiking for these stocks today » 10:40
04/05/24
04/05
10:40
04/05/24
10:40
ABIO

ARCA Biopharma

$3.07 /

-0.01 (-0.32%)

, ACOR

Acorda Therapeutics

$1.46 /

-0.255 (-14.87%)

, VNDA

Vanda Pharmaceuticals

$4.85 /

-0.065 (-1.32%)

, VBIV

VBI Vaccines

/

+

, CRNX

Crinetics

$47.58 /

+0.93 (+1.99%)

, ALDX

Aldeyra

$4.78 /

+0.11 (+2.36%)

, SIGA

Siga Technologies

$9.01 /

+0.035 (+0.39%)

, ABUS

Arbutus Biopharma

$3.21 /

+0.215 (+7.18%)

, GALT

Galectin Therapeutics

$3.16 /

+0.17 (+5.69%)

, NKTR

Nektar

$1.35 /

+0.02 (+1.50%)

These names in the…

Open Full Text

Over a month ago
Hot Stocks
Galectin Therapeutics appoints Khurram Jamil as VP, clinical development » 08:10
03/12/24
03/12
08:10
03/12/24
08:10
GALT

Galectin Therapeutics

$2.02 /

-0.01 (-0.49%)

Galectin announced the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
Hot Stocks
Galectin Therapeutics expects cash to fund operations through December 2024 » 08:03
11/13/23
11/13
08:03
11/13/23
08:03
GALT

Galectin Therapeutics

$2.08 /

+0.06 (+2.97%)

As of September 30, 2023,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Galectin Therapeutics reports Q3 EPS (24c) vs. (14c) last year » 08:02
11/13/23
11/13
08:02
11/13/23
08:02
GALT

Galectin Therapeutics

$2.08 /

+0.06 (+2.97%)

Joel Lewis, Chief…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Galectin Therapeutics nominates Benjamin Carson to board of directors » 08:07
10/12/23
10/12
08:07
10/12/23
08:07
GALT

Galectin Therapeutics

$2.07 /

-0.11 (-5.05%)

Galectin Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Galectin Therapeutics reports DSMB concludes NAVIGATE can continue as designed » 08:13
10/03/23
10/03
08:13
10/03/23
08:13
GALT

Galectin Therapeutics

$1.90 /

-0.01 (-0.52%)

Galectin Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Galectin Therapeutics to present update on belapectin liver cirrhosis program » 08:23
09/26/23
09/26
08:23
09/26/23
08:23
GALT

Galectin Therapeutics

$1.84 /

+0.06 (+3.37%)

Galectin Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Galectin Therapeutics to present data on liver cirrhosis at NASH meeting » 12:04
09/07/23
09/07
12:04
09/07/23
12:04
GALT

Galectin Therapeutics

$1.68 /

+ (+0.00%)

Galectin Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Galectin Therapeutics reports Q2 EPS (15c) vs (16c) last year » 08:12
08/14/23
08/14
08:12
08/14/23
08:12
GALT

Galectin Therapeutics

$1.48 /

+0.07 (+4.96%)

Joel Lewis, Chief…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Galectin Therapeutics reports Q4 EPS (19c) vs (17c) last year » 08:12
05/15/23
05/15
08:12
05/15/23
08:12
GALT

Galectin Therapeutics

$1.69 /

-0.06 (-3.43%)

Joel Lewis, Chief…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.